user

Aflibercept therapy for diabetic macular edema resistant to ranibizumab and bevacizumab

被引：0
|
作者：
Karth, Peter [1 ]
Moshfeghi, Darius M. [1 ]
Leng, Theodore [1 ]
机构：
[1] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
505; edema; 499 diabetic retinopathy; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1775
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
    Dan Călugăru
    Mihai Călugăru
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 1451 - 1452
  • [22] Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
    Calugaru, Dan
    Calugaru, Mihai
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (07) : 1451 - 1452
  • [23] Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
    Bahrami, Bobak
    Hong, Thomas
    Zhu, Meidong
    Schlub, Timothy E.
    Chang, Andrew
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (06) : 1133 - 1140
  • [24] Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
    Bobak Bahrami
    Thomas Hong
    Meidong Zhu
    Timothy E. Schlub
    Andrew Chang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 1133 - 1140
  • [25] Clinical Outcomes of Eyes With Diabetic Macular Edema Switched From Aflibercept to Ranibizumab Therapy
    Mellen, Phoebe L.
    Obeid, Anthony
    Wibbelsman, Turner D.
    Hsu, Jason
    Konkoly, Michelle A.
    Velez, Michael R.
    Calem, Daniel B.
    Sioufi, Kareem
    Jenkins, Thomas L.
    Xu, David
    Chiang, Allen
    Gupta, Omesh P.
    Spirn, Marc
    Regillo, Carl D.
    Ho, Allen C.
    Klufas, Michael A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2020, 51 (12): : 691 - 697
  • [26] Ranibizumab or Aflibercept Therapy with Dexamethosone Intravitreal Injection Efficacy in Diabetic Macular Edema.
    Nassaralla, Joao J.
    Nassaralla, Arthur A.
    Amaro, Miguel Hage
    Nassaralla, Joao J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [27] Letter to the Editor: Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
    Calugaru, Dan
    Calugaru, Mihai
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (04): : 280 - 280
  • [28] Macular Ischemia Changes in Patients with Diabetic Macular Edema Treated with Aflibercept and Ranibizumab
    Maris, Dimitrios
    Dastiridou, Anna
    Kotoula, Maria
    Karathanou, Aikaterini
    Tsironi, Evangelia E.
    Bargiota, Alexandra
    Androudi, Sofia
    DIAGNOSTICS, 2024, 14 (12)
  • [29] Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
    Nawar, Amin E.
    Wasfy, Tamer
    Shafik, Heba M.
    BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [30] Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
    Amin E. Nawar
    Tamer Wasfy
    Heba M. Shafik
    BMC Ophthalmology, 22
12345